Evidence map›Paper›PMID 21827433›Full record

ArticleInfectious disorders drug targets2011

Overview of the diagnosis of cytomegalovirus infection.

S A Ross, Z Novak, S Pati, S B Boppana

Open access · greenAbstract read
In one paragraph

Article in Infectious disorders drug targets, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 231 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S A RossDepartments of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA. sross@peds.uab.edu
Z Novak
S Pati
S B Boppana
University of Alabama at Birmingham · US

Funding

Viral determinants of Cytomegalovirus related hearing lossK23DC008539 · NIDCD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROSS, SHANNON A · 2007 to 2011
$733k
Congenital CMV Infection and Hearing Loss in Rural Indian PopulationR03HD061090 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BOPPANA, SURESH B · 2009 to 2010
$142k
NICHD NIH HHS 1 R03 HD061090NICHD NIH HHS R03 HD061090NIDCD NIH HHS K23 DC008539NIDCD NIH HHS N01 DC050008
6 · The paper itself

Abstract

Cytomegalovirus (CMV) is recognized as the most common congenital viral infection in humans and an important cause of morbidity and mortality in immunocompromised hosts. This recognition of the clinical importance of invasive CMV disease in the setting of immunodeficiency and in children with congenital CMV infection has led to the development of new diagnostic procedures for the rapid identification of CMV. Diagnosis of acute maternal CMV infection by the presence of immunoglobulin (Ig)M and low-avidity IgG requires confirmation of fetal infection, which is typically performed using polymerase chain reaction (PCR) assays for CMV on amniotic fluid. Viral culture of the urine and saliva obtained within the first two weeks of life continues to be the gold standard for diagnosis of congenitally-infected infants. PCR assays of dried blood spots from newborns have been shown to lack sufficient sensitivity for the identification of most neonates with congenital CMV infection for universal screening purposes. However, saliva PCR assays are currently being assessed as a useful screening method for congenital CMV infection. In the immunocompromised host, newer rapid diagnostic assays, such as phosphoprotein 65 antigenemia and CMV real-time PCR of blood or plasma have allowed for preemptive treatment, reducing morbidity and mortality. However, lack of standardized real-time PCR protocols hinders the comparison of data from different centers and the development of uniform guidelines for the management of invasive CMV infections in immunocompromised individuals.

Indexed as

ChildCytomegalovirusCytomegalovirus InfectionsFemaleFetal DiseasesHumansImmunocompromised HostImmunoglobulin GImmunoglobulin MInfant, NewbornInfectious Disease Transmission, VerticalMass ScreeningPolymerase Chain ReactionPractice Guidelines as TopicPregnancyPregnancy Complications, InfectiousImmunoglobulin GImmunoglobulin M

Identifiers

PMID21827433
PMCPMC3730495
OpenAlexW2118382376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.